Powered by ZigaForm version

Pharmacovigilance Newsletter

The PV/PMS Directorate sends out quarterly newsletters to stakeholders. The objectives of the newsletters are to:

  • Disseminate information on pharmacovigilance activities nationally and globally
  • Educate stakeholders on medicines safety issues
  • Promote rational use of medicines and
  • Promote spontaneous reporting of Adverse Drug Reactions(ADRs)

The newsletters are circulated to stakeholders via email. They can also be accessed below.

Contact us via fdic@nafdac.gov.ng if you would like the Newsletters delivered directly to your mail.

TitleVolume Year Published
Pharmacovigilance in Public Health Programmes NewsletterVol. 15 No. 22023
Recent Developments in Nigerian Implementation of Good Distribution Practices of Pharmaceutical ProductsVol. 15 No. 12022
New Developments And Activities Of The National Pharmacovigilance Centre In The Year 2020 And 2021Vol. 14 No. 22021
Pharmacovigilance A View Of Medical DevicesVol. 13 No. 32020
Regulation And Control Of Medical Product In A PandemicVol. 13 No. 22020
Fluoroquinolones and risk of disabling and potentially irreversible side effectsVol. 13 No. 12020
Circulation of falsified antimalaria and antibiotics in subsaharan AfricaVol. 12 No. 22019
Activities At The National Pharmacovigilance Center In The Year 2018Vol. 12 No. 12019
Sulfadoxine/Pyrimethamine and Stevens-Johnson SyndromeVol. 11 No. 12018
Review of Pediatric PharmacovigilanceVol. 92016
Rational Use Of MedicinesVol. 8, No. 12015
Pharmacovigilance Of Antidiabetic DrugsVol. 7 No. 32014
Antibiotic Resistance And PharmacovigilanceVol. 7 No. 22014
Overview Of Tuberculosis Infection And DiseaseVol. 7 No. 12014
Pharmacovigilance Of VaccinesVol. 6 No. 22013
National Pharmacovigilance PolicyVol. 6 No. 12013
Pharmacovigilance Of Act AntimalarialsVol. 5 No. 32011
Stevens Johnson SyndromeVol. 5 No. 22011
Pharmacovigilance And The Use Of AntibioticsVol. 4 No. 3
Pharmacovigilance Of Antihypertensive MedicinesVol. 4 No. 1
Pharmacovigilance Of Antiretroviral MedicinesVol. 3 No. 3
Zonal Training Workshop For Institutional Drug Safety Monitoring OfficersVol. 2
Description Of AdRs Received By The NPC That Were Due To AnalgesicsVol. 1 No. 4
Summary Of ADR On The NPC Database (Special Attention On Antibiotics)Vol. 1 No. 3
Introducing The PVG/FDIC NewsletterVol. 1 No. 1

Was this post helpful?